Giant fertiliser combo looks tough to cultivate

September 23, 2014

Norway’s Yara is talking to U.S. rival CF Industries about a $27 bln tie-up. The two boast similar valuations and could reap sizeable synergies. Hence a near-$1 bln jump in Yara’s market cap. But a merger of equals is one of the trickiest deal varieties.

Sovereign funds still hungry for Western banks

July 19, 2012

Bad early-crisis bets haven’t put rich states off backing global lenders. Qatar and Norway have upped their exposure to Credit Suisse, while Singapore’s Temasek has joined the throng. The enthusiasm reflects a lack of attractive alternatives, as much as hopes for a recovery.

Bayer can pay more for cancer blockbuster partner

November 26, 2013

The German drugmaker has made a preliminary 1.8 bln euro bid for Norwegian partner Algeta. The target’s shares immediately priced in a higher offer. That looks right. A counterbidder is unlikely. But Algeta’s cancer drug has huge potential and Bayer can afford to pay more.

Norway SWF wages lone governance crusade

October 8, 2009

Norway's $420 billion oil fund is rattling the cage of some of the foreign companies in which it has invested. As a shareholder it deserves praise for putting its head above the parapet. But as a sovereign wealth fund it is treading a fine line.